Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 13Breast 10Genitourinary 9Lymphoid 7Gynecologic 6Other 5Other hematologic neoplasm 4Dermatologic 3Thoracic 2Endocrine 2Other solid neoplasm 1Other neoplasm 1Head & Neck 1

Conditions

Neuroendocrine Tumors 378Pituitary Neoplasms 159Multiple Endocrine Neoplasia Type 1 150Thyroid Cancer, Papillary 122Pheochromocytoma 107Carcinoma, Neuroendocrine 93Thyroid Neoplasms 74Paraganglioma 68Carcinoid Tumor 66Neoplasms 54Thyroid Carcinoma, Anaplastic 50Adrenocortical Carcinoma 47Adrenal Gland Neoplasms 46Neoplasm Metastasis 40Insulinoma 39Pancreatic Neoplasms 36Gastro-enteropancreatic neuroendocrine tumor 36Adenoma, Islet Cell 36Carcinoma, Medullary 29Neuroblastoma 28Adenocarcinoma, Follicular 28Hyperaldosteronism 25Prostatic Neoplasms 24Lung Neoplasms 24Obesity 23Brain Neoplasms 22Pituitary Diseases 21Differentiated Thyroid Cancer 20Cushing Syndrome 20Sarcoma 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Health Behavior × Endocrine × Clear all
NCT03781453 2020-04-08

POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

University of British Columbia

Phase NA Completed
498 enrolled
Endocrine

Behavior, Health Behavior, Multiple Endocrine Neoplasia Type 1

NCT03548077 2019-10-08

POWERPLAY

University of British Columbia

Phase NA Completed
227 enrolled
Endocrine

Behavior, Neoplasms, Health Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡